Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The Details of Moderna's Award HHS reported that it had provided the drug maker with the funds in order "to accelerate the development of mRNA-based pandemic influenza vaccines and enhance (its ...

The 5′ end of substrate mRNA dramatically affects its ability to be cleaved by RNase E: the rate constant for 5′-monophosphate RNA is more than an order of magnitude greater than that for RNA ...

The global fight against cancer is at a pivotal moment. A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine. This revolutionary ...

Making the world smarter, happier, and richer.

Another kind of RNA therapy that has been approved by regulators in the U.S. and Europe alike, are antisense oligonucleotides. These work by binding to specific mRNA sequences in order to modify gene ...

Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of influenza that could form the basis of a future universal jab.

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...